Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2023.0743
Abstract: Key Points Question Is treatment with nirmatrelvir in the acute phase of SARS-CoV-2 infection associated with a lower risk of post–COVID-19 condition (PCC)? Findings In this cohort study of 281 793 people with SARS-CoV-2 infection who… read more here.
Keywords: reduced risk; risk post; risk; treatment nirmatrelvir ... See more keywords
Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.45086
Abstract: Key Points Question What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir? Findings In this cohort study of 12 629 adults in Hong Kong with COVID-19 who were hospitalized and had serial… read more here.
Keywords: nirmatrelvir ritonavir; ritonavir molnupiravir; viral rebound; treatment nirmatrelvir ... See more keywords